From: Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT)
Patient characteristics at the time of SBRT | |
---|---|
Median age, years (range) | 71 (41–94) |
Median KPS (range) | 80 (60–100) |
Gender, N | |
Female | 19 |
Male | 20 |
History of tobacco use, N (%) | 39 (100%) |
COPD, N (%) | 22 (56%) |
Median follow-up, months (range) | 12.6 (1.3-47.5) |
Median interval between fractionated RT and SBRT, months (range) | 37 (1–180) |
Type of initial radiation, N | |
Conventional | 13 |
3D-CRT | 12 |
IMRT | 14 |
Median prior radiation dose, Gy (range) | 61 (30–80) |
History of thoracic surgery, N (%) | 21 (54%) |
History of chemotherapy, N (%) | 22 (56%) |
Diagnosis, N | |
Primary lung cancer | 17 |
Stage I-II | 15 |
Stage III | 1 |
Stage IV | 1 |
Recurrent lung cancer | 18 |
Localized | 16 |
Metastatic | 2 |
Other histologies | 4 |